-
ICD-10-CM Codes
›
-
C00-D49
Neoplasms
›
-
C81-C96
Malignant neoplasms of lymphoid, hematopoietic and related tissue
›
-
C92-
Myeloid leukemia
›
2018 ICD-10-CM Diagnosis Code C92
Myeloid leukemia
2016 2017 2018 Non-Billable/Non-Specific Code
- C92 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2018 edition of ICD-10-CM C92 became effective on October 1, 2017.
- This is the American ICD-10-CM version of C92 - other international versions of ICD-10 C92 may differ.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C92. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
IncludesIncludes Help
"Includes" further defines, or give examples of, the content of the code or category.
- granulocytic leukemia
- myelogenous leukemia
The following code(s) above
C92 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
C92:
- A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia.
- A progressive, proliferative disease of blood cells, originating from immature granulocytes.
- Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (myeloid progenitor cells) in the bone marrow and other sites.
- Leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors in the bone marrow and other sites.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
Code annotations containing back-references to C92:
ICD-10-CM Codes Adjacent To C92
C91.Z Other lymphoid leukemia
C91.Z0 …… not having achieved remission
C91.9 Lymphoid leukemia, unspecified
C91.90 …… not having achieved remission
C92
Myeloid leukemia
C92.0 Acute myeloblastic leukemia
C92.00 …… not having achieved remission
C92.1 Chronic myeloid leukemia, BCR/ABL-positive
C92.10 …… not having achieved remission
C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negative
C92.20 …… not having achieved remission
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
